1. Home
  2. LODE vs CNTN Comparison

LODE vs CNTN Comparison

Compare LODE & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Inc.

LODE

Comstock Inc.

HOLD

Current Price

$3.27

Market Cap

229.1M

Sector

Industrials

ML Signal

HOLD

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$3.13

Market Cap

184.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LODE
CNTN
Founded
2008
2017
Country
United States
United States
Employees
N/A
3
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.1M
184.2M
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
LODE
CNTN
Price
$3.27
$3.13
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
1.1M
429.0K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
63.55
N/A
EPS
N/A
N/A
Revenue
$1,553,796.00
N/A
Revenue This Year
$1,429.67
N/A
Revenue Next Year
$270.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.85
$3.07
52 Week High
$4.80
$5.27

Technical Indicators

Market Signals
Indicator
LODE
CNTN
Relative Strength Index (RSI) 54.15 30.76
Support Level $3.11 $3.11
Resistance Level $3.43 $3.51
Average True Range (ATR) 0.24 0.26
MACD 0.06 0.01
Stochastic Oscillator 68.50 12.12

Price Performance

Historical Comparison
LODE
CNTN

About LODE Comstock Inc.

Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Share on Social Networks: